XTX Topco’s Scinai Immunotherapeutics SCNI Stock Holding History

XTX Topco’s Portfolio SCNI Stock Details SCNI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.3K	Sell	24,041 -3,253	-12%	-$2.62K	﹤0.01%	3639
2025 Q4	$19.4K	Buy	+27,294	New	+$31.1K	﹤0.01%	3065

Other funds holding SCNI

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

XTX Topco's SCNI Position: Q1 2026 in Review

XTX Topco reduced its Scinai Immunotherapeutics (SCNI) stake by 12% in Q1 2026, selling an estimated $2.62K and leaving 24,041 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3639.

XTX Topco first reported a position in SCNI in Q4 2025 and has held it in 2 quarters since. The position peaked at $19.4K in Q4 2025. 4 funds tracked by Wall St. Rank hold SCNI as of Q1 2026.

XTX Topco held 24,041 shares of Scinai Immunotherapeutics worth $13.3K as of Q1 2026.
XTX Topco sold 3,253 Scinai Immunotherapeutics shares in Q1 2026, an estimated $2.62K.
Scinai Immunotherapeutics made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3639 holding.
XTX Topco first reported a position in Scinai Immunotherapeutics in Q4 2025 and has held it in 2 quarters since.
XTX Topco's Scinai Immunotherapeutics position peaked at $19.4K in Q4 2025.
4 funds tracked by Wall St. Rank held Scinai Immunotherapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.